FDA Awards Biosearch Technologies $3.4 MM Contract

The FDA has awarded Biosearch Technologies a five year contract for the development of multiplexed, fluorescent bead-based assays to determine bioterror and food safety pathogens.  The assay will be conducted on a Luminex® xMap® platform.  Throughout the contract, Biosearch will collaborate with scientists at Lawrence Livermore National Laboratories (LLNL) and the Luminex Corporation to develop assays for agents listed by the CDC and USDA.  Initial target analytes include Bacillus anthracis, the causative agent of anthrax; Yersinia pestis, the causative agent of the plague; and Francisella tularensis, the causative agent of tularemia.

To read the entire story, read the full press release.